Autor:	Felley C; Service de gastro-entérologie et hépatologie, CHUV, 1011 Lausanne., Mottet C, Hess J, Juillerat P, Guyot J, Delarive J, Michetti P
Jazyk:	francouzština
Zdroj:	Revue medicale suisse [Rev Med Suisse] 2007 Jan 24; Vol. 3 (95), pp. 201-2, 204-6, 208-14.
Abstrakt:	There was no real therapeutic advances in inflammatory bowel diseases last year. In addition to infliximab, new anti-TNF-alpha agents will soon become available.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu